These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 21148255

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
    Boyer O, Noël LH, Balzamo E, Guest G, Biebuyck N, Charbit M, Salomon R, Frémeaux-Bacchi V, Niaudet P.
    Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
    [Abstract] [Full Text] [Related]

  • 44. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
    Johnson SA, Williams JM, Hakobyan S, Richards A, Perkins SJ, Marchbank KJ, Goodship TH, Morgan BP, Taylor CM, Savage CO.
    Mol Immunol; 2010 Apr; 47(7-8):1585-91. PubMed ID: 20304497
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.
    Frimat M, Tabarin F, Dimitrov JD, Poitou C, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT.
    Blood; 2013 Jul 11; 122(2):282-92. PubMed ID: 23692858
    [Abstract] [Full Text] [Related]

  • 48. Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.
    Kerr H, Wong E, Makou E, Yang Y, Marchbank K, Kavanagh D, Richards A, Herbert AP, Barlow PN.
    J Biol Chem; 2017 Aug 11; 292(32):13345-13360. PubMed ID: 28637873
    [Abstract] [Full Text] [Related]

  • 49. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
    Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S.
    Kidney Int; 2018 Feb 11; 93(2):450-459. PubMed ID: 28911789
    [Abstract] [Full Text] [Related]

  • 50. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
    Fan X, Yoshida Y, Honda S, Matsumoto M, Sawada Y, Hattori M, Hisanaga S, Hiwa R, Nakamura F, Tomomori M, Miyagawa S, Fujimaru R, Yamada H, Sawai T, Ikeda Y, Iwata N, Uemura O, Matsukuma E, Aizawa Y, Harada H, Wada H, Ishikawa E, Ashida A, Nangaku M, Miyata T, Fujimura Y.
    Mol Immunol; 2013 Jun 11; 54(2):238-46. PubMed ID: 23314101
    [Abstract] [Full Text] [Related]

  • 51. Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.
    Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B.
    Am J Kidney Dis; 2005 Feb 11; 45(2):415-21. PubMed ID: 15685522
    [Abstract] [Full Text] [Related]

  • 52. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.
    Ruseva MM, Vernon KA, Lesher AM, Schwaeble WJ, Ali YM, Botto M, Cook T, Song W, Stover CM, Pickering MC.
    J Am Soc Nephrol; 2013 Jan 11; 24(1):43-52. PubMed ID: 23184055
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.
    Clin J Am Soc Nephrol; 2010 Oct 11; 5(10):1844-59. PubMed ID: 20595690
    [Abstract] [Full Text] [Related]

  • 57. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.
    Pediatr Nephrol; 2016 May 11; 31(5):759-68. PubMed ID: 26604087
    [Abstract] [Full Text] [Related]

  • 58. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E, Alberti M, Iatropoulos P, Piras R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S, Amoroso A, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2019 May 11; 10():853. PubMed ID: 31118930
    [Abstract] [Full Text] [Related]

  • 59. Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.
    Geerlings MJ, Volokhina EB, de Jong EK, van de Kar N, Pauper M, Hoyng CB, van den Heuvel LP, den Hollander AI.
    Clin Genet; 2018 Oct 11; 94(3-4):330-338. PubMed ID: 29888403
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.